RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of Hold from Analysts

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen analysts that are currently covering the company, Marketbeat Ratings reports. Nine analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among […]

Related Keywords

United States ,Leerink Partnrs ,Vanguard Group Inc ,Nasdaq ,Rapt Therapeutics Inc ,Entrypoint Capital ,Cantor Fitzgerald ,Therapeutics Company Profile ,Therapeutics Inc ,Acadian Asset Management ,Jpmorgan Chase Co ,Redmile Group ,Barclays ,Get Free Report ,Marketbeat Ratings ,Point Capital ,Asset Management ,Vanguard Group ,Get Free ,